首页> 美国卫生研究院文献>Oncotarget >miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas
【2h】

miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas

机译:miR-146b-5p通过靶向TRAF6发挥抑癌作用并预测人类神经胶质瘤的预后

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Down-regulation of miR-146b-5p contributes to tumorigenesis in several human cancers. However, the relevance of miR-146b-5p to prognosis, proliferation and apoptosis in gliomas remains unknown. In the present study, we demonstrated that miR-146b-5p expression was inversely correlated with grades and Ki-67 index in 147 human glioma specimens, but positively correlated with patients’ survival. Furthermore, two distinct subgroups of patients with grade I-IV gliomas with different prognoses were identified according to miR-146b-5p expression in our specimens. Cox regression showed that miR-146b-5p was an independent predictor for patients’ survival. Overexpression of miR-146b-5p dramatically suppressed glioma cell proliferation and induced apoptosis. Mechanistically, we validated TRAF6 as a direct functional target of miR-146b-5p and found that miR-146b-5p overexpression significantly decreased phosphorylated TAK1 and IκBα, the pivotal downstream effectors of TRAF6. Moreover, TRAF6 expression was positively correlated with glioma grades and Ki-67 index but inversely correlated with miR-146b-5p expression and predicted poor prognosis of glioma patients. In glioblastoma cell lines, silencing of TRAF6 could mimic the anti-tumor effect of miR-146b-5p. Our findings identify miR-146b-5p as a tumor suppressor and novel prognostic biomarker of gliomas, and suggest miR-146b-5p and TRAF6 as potential therapeutic candidates for malignant gliomas.
机译:miR-146b-5p的下调有助于几种人类癌症的发生。然而,miR-146b-5p与神经胶质瘤的预后,增殖和凋亡的相关性仍然未知。在本研究中,我们证明了miR-146b-5p的表达与147个人类神经胶质瘤标本的等级和Ki-67指数呈负相关,但与患者的生存呈正相关。此外,根据我们的标本中miR-146b-5p的表达,确定了I-IV级神经胶质瘤患者不同预后的两个不同亚组。 Cox回归显示,miR-146b-5p是患者生存的独立预测因子。 miR-146b-5p的过表达显着抑制神经胶质瘤细胞的增殖并诱导凋亡。从机制上讲,我们验证了TRAF6是miR-146b-5p的直接功能靶标,发现miR-146b-5p的过表达显着降低了TRAF6的关键下游效应物磷酸化TAK1和IκBα。此外,TRAF6表达与神经胶质瘤等级和Ki-67指数呈正相关,而与miR-146b-5p表达呈负相关,并预测脑胶质瘤患者的预后不良。在胶质母细胞瘤细胞系中,TRAF6沉默可以模拟miR-146b-5p的抗肿瘤作用。我们的发现确定miR-146b-5p是神经胶质瘤的抑癌药和新的预后生物标志物,并暗示miR-146b-5p和TRAF6是恶性神经胶质瘤的潜在治疗候选物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号